LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Menarini Introduces PRIME MDx All-in-One Molecular Diagnostics Solution

By LabMedica International staff writers
Posted on 23 May 2023
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)
Image: PRIME MDx all-in-one, sample-to-result, fully automated solution (Photo courtesy of Menarini)

Menarini Diagnostics (Florence, Italy) is presenting its range of innovative professional diagnostics solutions in the field of molecular diagnostics, autoimmunity testing, hemoglobin analysis, and immunoassay testing at EuroMedLab Rome 2023.

The main highlight at Menarini's booth during this industry event is the brand new PRIME MDx all-in-one solution. This fully automated sample-to-result system is specifically designed to streamline laboratory workflows for real-time PCR diagnostic assays, offering exceptional efficiency, flexibility, and ease of use. With its automation and guided instrument setup, PRIME MDx minimizes manual intervention and ensures full sample traceability. Dedicated software enables automatic result generation and interpretation, leading to high-quality results, workflow standardization, and improved laboratory efficiency. The continuous workflow feature allows users to initiate a new loading process (extraction/setup) while a previous PCR is still running. PRIME MDx offers the flexibility to manage runs with various extraction reagent formats (prefilled or standard) and seamlessly integrates with existing IT infrastructure.

At the 2023 WordLab-EuroMedLab Congress, Menarini is also presenting the Zenit range of high-throughput innovations. This includes the Zenit PRIME random access chemiluminescence analyzer, catering to the autoimmunity laboratory's needs with its comprehensive panel of reagents and advanced features. The walk-away system boasts a throughput of up to 120 tests/hour, with continuous loading and random access to samples, specific and common reagents, and consumables, enabling efficient operation within an 8-hour timeframe (1000 tests).

In addition, Menarini is showcasing the winning combination of Zenit flow and Zenit fast in IIF (Indirect Immunofluorescence) slide processing and scanning. The Zenit flow automated IIF slide processor performs all necessary steps, from sample dilution to coverslip mounting, resulting in improved standardization and a flexible, optimized workflow within the laboratory. The Zenit flow is complimented by the Zenit fast automated diagnostics system for the acquisition, analysis, and storage of IFA (Immunofluorescence Assay) slides. It provides laboratories with an efficient solution to enhance the management of IFA tests, standardize the validation procedure, and reduce intra- and inter-laboratory variability. Some noteworthy features of Zenit fast include image autofocusing technology, whole-well scanning capability, software algorithms for IFA detection and pattern recognition, run-time efficiency, recognition of various ANA (Antinuclear Antibody) IFA patterns, and the ability to analyze different IFA substrates.

Related Links:
Menarini Diagnostics 

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
ESR Analyzer
TEST1 2.0
Gold Member
Hematology Analyzer
Medonic M32B

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more